Concepedia
Statistics
Publications
13
Citations
1.5K
H-Index
11
Active since
1995
Affiliations
Merck (Germany)(Current)
Johannes Gutenberg University Mainz
Institute of Cancer Research
Ono Pharmaceutical (United States)
Newcastle University
Thomas Grombacher is an author at Merck (Germany) specializing in medicine, cell biology, and molecular biology.
Top concepts
MedicineCell BiologyMolecular BiologyTumor BiologyRadiation OncologyGeneticsOncologyChromatinPharmacologyCancer Therapy
Publications per year
1995–2024
Combining Global and Local Measures for Structure-Based Druggability Predictions
Andrea Volkamer, Daniel Kühn, Thomas Grombacher et al. · Journal of Chemical Information and Modeling · 2011 · 481 citations
Analyzing the Topology of Active Sites: On the Prediction of Pockets and Subpockets
Andrea Volkamer, Axel Griewel, Thomas Grombacher et al. · Journal of Chemical Information and Modeling · 2010 · 285 citations
Protein Active Sites, Engineering, Active Sites +24
Pharmacologic Inhibitor of DNA-PK, M3814, Potentiates Radiotherapy and Regresses Human Tumors in Mouse Models
Frank T. Zenke, Astrid Zimmermann, Christian Sirrenberg et al. · Molecular Cancer Therapeutics · 2020 · 158 citations
p53 is involved in regulation of the DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) by DNA damaging agents
Thomas Grombacher, Uta Eichhorn, Bernd Kaina · Oncogene · 1998 · 138 citations
Genome Instability, Dna Damage, Chromatin Remodeling +4
Induction of the alkyltransferase (MGMT) gene by DNA damaging agents and the glucocorticoid dexamethasone and comparison with the response of base excision repair genes
Thomas Grombacher, Sankar Mitra, Bernd Kaina · Carcinogenesis · 1996 · 119 citations
1–5 of 13